Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Go back to Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
(NYSE: LCTX) Delayed: 1.27 -0.01 (0.78%)
Previous Close $1.28    52 Week High
Open $1.29    52 Week Low
Day High $1.31    P/E N/A 
Day Low $1.26    EPS
Volume 1,018,885       

(NYSE: LCTX) Delayed: 1.27 -0.01 (0.78%)
Previous Close $1.28    52 Week High
Open $1.29    52 Week Low
Day High $1.31    P/E N/A 
Day Low $1.26    EPS
Volume 1,018,885